BioSpace News Archive

Deals

Medivir’s Annual Report for 2018 is Published

Medivir AB announces that the Annual Report for 2018 now is available at the company’s website: www.medivir.com.

April 8, 2019
·
1 min read
Business

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

ACell, Inc. announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd.

April 8, 2019
·
3 min read
Business

Alnylam and Regeneron Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases

Companies to Also Jointly Advance Select Number of Preclinical Disease Programs with Targets Expressed in the Liver and Treatments for C5 Complement-Mediated Diseases

April 8, 2019
·
16 min read
Pharm Country

GenScript Launches Beta Testing Program for New Precision Mutant Library Services

Advanced semiconductor-based platform offers diverse libraries with complete coverage of only desired variants

April 8, 2019
·
3 min read
Drug Development

GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial

GT Biopharma, Inc. announced today it has received authorization from the University of Minnesota’s Institutional Review Board and Cancer Protocol Review Committee that it can proceed with its planned TriKE Phase 1 clinical trial.

April 8, 2019
·
10 min read
Biotech Beach

Veracyte Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype

RNA whole-transcriptome and machine learning platform enables genomic test to distinguish benign Hürthle cells, reducing potential for unnecessary surgeries

April 8, 2019
·
5 min read
Business

LifeScan Names Brian Heald as its New Head of Product

LifeScan announced today that it has named diabetes-device veteran Brian Heald as its new Head of Product effective immediately.

April 8, 2019
·
2 min read
Lifestyle Delivery Systems Inc. Announces CSPA Group, Inc. and Core Isogenetics, Inc. Shareholder Facility Experience Tour at the Annual General Meeting

Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces its wholly-owned subsidiaries, CSPA Group, Inc. and Core Isogenetics, Inc., will hold a shareholder facility tour for the Company’s shareholders on April 25, 2019.

April 8, 2019
·
4 min read
Business

IGF Oncology Appoints Gary G. Altman, Ph.D., as Chief Executive Officer

IGF Oncology, LLC, a clinical-stage biotech company developing targeted anti-cancer therapies with better efficacy and lower side effects compared to existing chemotherapy treatments, today named Gary G. Altman, Ph.D., as its new Chief Executive Officer

April 8, 2019
·
2 min read
Business

Schrödinger Receives Clinical-Stage Milestone Payment from Sanofi Collaboration

The companies are currently advancing programs in oncology and autoimmune disease.

April 8, 2019
·
2 min read